Clinical Trial Update: Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome? [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether a GnRH agonist trigger can prevent ovarian hyperstimulation syndrome has been terminated. The study lists Elisha Hospi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• GnRH agonist trigger (gonadotropin-releasing hormone agonist)

Snippet

Sponsor: Elisha Hospital | Conditions: Ovarian Hyperstimulation Syndrome | Phase 4 | Status: TERMINATED